Virbac SA - V16

Virbac SA produces and sells medicines and vaccines for companion and food-producing animals. The company offers Canigen vaccines; Clostrisan, a vaccine for the prevention of clostridiosis and botulism; Deltanil, a deltamethrin-based parasiticide for topical application; Effitix to treat tick, flea, and mosquito infestations; Epiotic, an ear cleanser; Eradia for the treatment of clostridium infections and giardiasis; and Fort Up, an injectable solution to control and treat gastro-intestinal and pulmonary parasiticides. It also provides Iverhart and Iverhart Max Soft Chew, a chewable tablets to prevent heartworm disease, as well as treat and control roundworms, hookworms, and tapeworms; Maxflor Duo/Maxflin, an antibiotic for the prevention and treatment of respiratory diseases; Milteforan, an oral treatment for canine leishmaniosis; Moxiheart, an internal parasiticide; and Multimin, a trace element injectable supplement. In addition, the company offers Nutribond to enhance dietary; Prinovox, an ectoparasiticide; Propofol, an anesthetic; Rilexine, a cephalexin-based antibiotic; Sentinel Flavor Tabs and Sentinel Spectrum, a polyvalent parasiticide tablets; Shotapen, a combination of antibiotics to treat bacterial infections; Speed Reader, a blood marker dosage analyzer; and Suprelorin, an implant to induce temporary infertility in male dogs. Further, it provides Tridectin, a parasiticide oral solution; Veterin, an antibiotic; Veterinary HPM, a petfood; and Zoletil, a multi-species general anaesthetic. Additionally, the company is involved in the production of moldings for third parties. It operates in France, rest of Europe, North America, Latin America, Asia, Pacific, and Africa and the Middle East. Virbac SA was founded in 1968 and is headquartered in Carros, France.